1. Home
  2. TRVG vs CRVS Comparison

TRVG vs CRVS Comparison

Compare TRVG & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVG
  • CRVS
  • Stock Information
  • Founded
  • TRVG 2005
  • CRVS 2014
  • Country
  • TRVG Germany
  • CRVS United States
  • Employees
  • TRVG N/A
  • CRVS N/A
  • Industry
  • TRVG EDP Services
  • CRVS Biotechnology: Pharmaceutical Preparations
  • Sector
  • TRVG Technology
  • CRVS Health Care
  • Exchange
  • TRVG Nasdaq
  • CRVS Nasdaq
  • Market Cap
  • TRVG 306.5M
  • CRVS 301.5M
  • IPO Year
  • TRVG N/A
  • CRVS 2016
  • Fundamental
  • Price
  • TRVG $3.88
  • CRVS $3.92
  • Analyst Decision
  • TRVG Buy
  • CRVS Strong Buy
  • Analyst Count
  • TRVG 4
  • CRVS 4
  • Target Price
  • TRVG $4.88
  • CRVS $15.00
  • AVG Volume (30 Days)
  • TRVG 65.6K
  • CRVS 736.8K
  • Earning Date
  • TRVG 07-29-2025
  • CRVS 08-05-2025
  • Dividend Yield
  • TRVG N/A
  • CRVS N/A
  • EPS Growth
  • TRVG N/A
  • CRVS N/A
  • EPS
  • TRVG N/A
  • CRVS N/A
  • Revenue
  • TRVG $522,618,892.00
  • CRVS N/A
  • Revenue This Year
  • TRVG $17.11
  • CRVS N/A
  • Revenue Next Year
  • TRVG $10.28
  • CRVS N/A
  • P/E Ratio
  • TRVG N/A
  • CRVS N/A
  • Revenue Growth
  • TRVG 1.70
  • CRVS N/A
  • 52 Week Low
  • TRVG $1.60
  • CRVS $1.75
  • 52 Week High
  • TRVG $5.83
  • CRVS $10.00
  • Technical
  • Relative Strength Index (RSI)
  • TRVG 40.11
  • CRVS 49.54
  • Support Level
  • TRVG $3.88
  • CRVS $3.83
  • Resistance Level
  • TRVG $4.09
  • CRVS $4.33
  • Average True Range (ATR)
  • TRVG 0.19
  • CRVS 0.28
  • MACD
  • TRVG -0.03
  • CRVS -0.03
  • Stochastic Oscillator
  • TRVG 17.39
  • CRVS 21.74

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).

Share on Social Networks: